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P2X receptors are cationic-selective ion channels gated by extracellular ATP. There are seven subunits (P2X1–7), the first six of which are
expressed throughout the peripheral and central nervous systems. P2X7 receptors are rapidly upregulated and activated as a result of
inflammatory stimuli in immune cells, where they act not only as cationic channels but uniquely couple with rapid release of proinflam-
matory cytokines, cytoskeletal rearrangements, and apoptosis or necrotic cell death. The P2X7 receptor has been termed the cytolytic
non-neuronal P2X receptor because it had not been detected in neurons until recently when it has been immunolocalized to several brain
regions, particularly the hippocampus, and has been suggested to be involved in presynaptic modulation of transmitter release. Because
its expression in brain neurons may have substantial functional implications, we have performed detailed immunocytochemical, immu-
noblot, and immunoprecipitation studies on brain and non-neuronal tissue using all currently available antibodies. We first examined
rats, but staining patterns were inconsistent among antibodies; we therefore studied mice for which there are two P2X7 knock-out mice
constructs available, one expressing the LacZ transgene. We found that P2X7 receptor protein is strongly and reliably detected in the
submandibular gland and lung of wild-type mice but not in either of the P2X7
/ mice. However, we failed to find evidence for P2X7
receptor protein in hippocampal neurons or their input– output projections. Either the P2X7 protein in the hippocampus is below the
limits of detection by the currently available methods or it is not present.
Key words: purinergic receptors; hippocampal neurons; immunocytochemistry; ligand-gated ion channels; transgenic animals; presyn-
aptic inhibition
Introduction
P2X7 receptors are unique ion channels; they have been studied
extensively in monocytes and macrophage, including brain mi-
croglia. In these cells, their activation not only opens cationic
channels and larger dye-permeable pores but also engages diverse
signal cascades associated with inflammatory states. These in-
clude initiation of a rapid release and processing of the proin-
flammatory cytokines interleukin-1 and caspase-1, induction of
rapid membrane blebbing and cytoskeletal rearrangements, acti-
vation of proapoptotic transcription factors and, depending on
the cell background and duration of stimulus, apoptotic or ne-
crotic cell death (Di Virgilio et al., 2001; Mackenzie et al., 2001;
Suh et al., 2001; Le Feuvre et al., 2002, 2003; Guerra et al., 2003;
Rothwell, 2003; Verhoef et al., 2003; Pfeiffer et al., 2004). These
receptors have excited much interest in immune cell biology and
drug development research as a promising target to treat inflam-
matory diseases, particularly arthritis, and the after-effects asso-
ciated with cerebral ischemic attacks (Alcaraz et al., 2003; Baxter
et al., 2003; Guerra et al., 2003; Rothwell, 2003). Much of this
therapeutic interest stems from the notion that P2X7 receptors
are relatively specifically expressed in cells of the immune system,
where they are rapidly upregulated and activated after initial in-
flammatory stimuli.
Initial studies showed mRNA for the P2X7 receptor in many
immune, endothelial, and epithelial cells but not in peripheral or
central neurons; in the brain, significant mRNA expression was
observed only in ependymal cells lining the ventricles and in
activated microglia from ischemic rat and mouse brain (Collo et
al., 1997). More recently, protein expression studies revealed
similar non-neuronal localizations, but these have also shown
immunostaining in many brain neurons, at both presynaptic and
postsynaptic densities (Deuchars et al., 2001; Armstrong et al.,
2002; Atkinson et al., 2002, 2004; Lundy et al., 2002; Sperlagh et
al., 2002; Ishii et al., 2003; Cavaliere et al., 2004). However, im-
munostaining patterns in neurons have been inconsistent (Deu-
chars et al., 2001; Armstrong et al., 2002; Atkinson et al., 2002;
Sperlagh et al., 2002; Ishii et al., 2003; Lundy et al., 2003; Atkinson
et al., 2004). Although the panopoly of consequences of activa-
tion of this ion channel may well be functionally relevant in the
immune system, it is difficult to see a role for P2X7 receptors on
neurons. Given the limitations to available antibodies (Abs), as
well as the difficulty in interpreting functional studies without
adequate antagonists, this prompted the need to reexamine the
expression of the receptor on mammalian neurons.
In the present study, we sought to determine the protein ex-
pression pattern of the P2X7 receptor in adult rodent brain and to
compare this with results from parallel experiments on subman-
dibular gland and lung. We examined most areas of the brain but
focused our studies on the hippocampus because this is the re-
gion where most of the current evidence for the functional ex-
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pression of the P2X7 receptor has been obtained (Deuchars et al.,
2001; Armstrong et al., 2002; Lundy et al., 2002; Sperlagh et al.,
2002; Atkinson et al., 2004). We performed immunocytochemis-
try, Western blotting, and immunoprecipitation experiments us-
ing three separate Abs directed at different epitopes of the P2X7
protein and on two sets of P2X7 receptor knock-out mice gener-
ated using different strategies. One of these incorporated a LacZ
insertion into the P2X7 gene, which allowed determination of
-galactosidase protein expression of the transgene. We can find
no evidence for protein expression of P2X7 receptors in hip-
pocampal neurons or their input– output projections.
Materials and Methods
Animals used in the present study were male C57BL/6 mice (40 –50 d
old), P2X7 knock-out mice derived from Pfizer (Groton, CT) and their
corresponding wild-type B6D2 (C57B/L6DBA/2 F1) and P2X7 knock-
out mice derived from GlaxoSmithKline (Harlow, UK) with their
C57B/L6 controls. Male Wistar rats (250 gm) were used in initial exper-
iments. All experiments were performed under a United Kingdom Home
Office License and in accordance with the regulations of the United
Kingdom Animal (Scientific Procedures) Act (1986). Generation of the
transgenic mice has been described (Sikora et al., 1999; Solle et al., 2001).
Briefly, the Glaxo mice had a lacZ gene inserted at the beginning of the
exon 1 region of the P2X7 gene, whereas Pfizer mice were constructed by
a deletion in the region containing aa 506 –532, followed by an insertion
of a neomycin cassette in a 3 to 5 direction (Fig. 1). Using DNA isolate
from ear tag, mice derived from Pfizer were genotyped as described by Le
Feuvre et al. (2002), and mice from Glaxo were genotyped for lacZ inser-
tion in the exon 1 region of P2X7 (I. Chessell, personal communication).
All mice used were genotyped immediately before use.
Immunocytochemistry. Adult male mice and rats were anesthetized
with intraperitoneal Sagatal (60 mg/kg) and were perfused transcardially
with 10 ml of saline containing heparin at room temperature, followed by
cold fixative containing 4% paraformaldehyde in 0.1 M phosphate buffer,
pH 7.4. All experiments were performed under a United Kingdom Home
Office License and in accordance with the regulations of the United
Kingdom Animal (Scientific Procedures) Act (1986). Whole brains were
removed and postfixed in the same solution for 2 hr at 4°C. Tissues were
then transferred to 30% sucrose in 0.1 M phosphate buffer at 4°C for 2 d.
Serial 40 m sections were cut in cold TBS, pH 7.4, on a Vibratome
(Leica, Milton Keynes, UK) and collected in multiwells containing TBS
and processed for P2X receptor immunocytochemistry. Lung and sub-
mandibular glands were removed and embedded in optimal cutting tem-
perature compound (Bright Instruments, Huntingdon, UK), frozen on
dry ice, sectioned at 10 m, and collected on SuperFrost Plus slides
(VWR Scientific, West Chester, PA). In some experiments, brains were
removed from nonperfused animals and treated similarly to lung and
submandibular glands for comparative studies. The tissues were post-
fixed in 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, before
being processed for P2X receptor immunocytochemistry.
The immunocytochemistry procedure used in the present study was
modified and adapted from those described previously (Skynner et al.,
1999). We used two commercially available Abs [Cterm-Ab (epitope
567-595) and ectoAb-1 (epitope 136-152); Alomone, Jerusalem, Israel)
and a polyclonal ecto-domain Ab (ectoAb-2; a gift from J. Barden, Uni-
versity of Sydney, Sydney, Australia) (Fig. 1). Free-floating sections and
sections on slides were incubated in TBS solution containing 1% H2O2
and 40% methanol for 5 min, followed by three washes in TBS. Sections
were then incubated for 1 hr at room temperature in preblocking TBS
solution (bTBS) comprising of 5% NGS, 0.3% BSA, and 0.3% Triton
X-100. Both permeabilized and nonpermeabilized (detergent-free bTBS)
conditions were examined with both ecto-domain Abs. The free-floating
sections were then incubated in either Cterm-Ab (0.30g/ml), ectoAb-1
(0.15 g/ml), or ectoAb-2 (1:2000 dilution) for 24 – 48 hr at 4°C. After
the primary Ab incubation, sections were rinsed (three washes for 15 min
each) in TBS and exposed to goat biotinylated anti-rabbit secondary Ab
complex (1:200; Vector Laboratories, Peterborough, UK) for 90 min
before a 15 min incubation in HRP streptavidin (Vector Laboratories) at
room temperature. The sections were washed again in TBS and finally
reacted with the nickel–DAB chromagen using glucose oxidase. Controls
consisted of the omission of the primary Abs from the immunostaining
protocol and the use of P2X7 Abs preadsorbed with the corresponding
peptide (for P2X from Alomone at 5 g/ml final concentration as in-
structed by the manufacturer). The free-floating sections were then
mounted onto gelatinized glass slides and air dried. All slides were dehy-
drated in series of ethanol (70, 80, 90, 95, and 100%) and cleared in
xylene. Sections were mounted in DPX (BDH Chemicals, Poole, UK) and
examined with a BX40 microscope (Olympus, Lake Success, NY). Images
were taken with a digital SPOT camera and software (Diagnostic Instru-
ments, Sterling Heights, MI).
Western blotting and immunoprecipitation. HEK293 cells were tran-
siently transfected with mouse P2X7 receptors using Lipofectamine 2000
(Invitrogen, San Diego, CA) according to standard protocols. Animals
were killed by excess anesthesia (isoflurane), and their tissues were re-
moved quickly. Whole brain, lung, and submandibular glands were col-
lected from wild-type P2X7
/, Pfizer wild-type P2X7
/, Pfizer
P2X7
/, and GlaxoP2X7
/ mice and placed in cold PBS containing
protease inhibitor (Complete; Roche Molecular Biochemicals, Stock-
holm, Sweden). The Abs used were the same as those for immunohisto-
chemistry. Goat anti-rabbit HRP-conjugated secondary Ab was obtained
from DAKO Cytomation. Mouse tissues were homogenized as follows:
tissues were cut into small (1 mm 2) pieces and incubated in 3 ml of
ice-cold hypotonic lysis buffer (10 mM Tris-HCl, pH 7.4, 1 mM MgCl2,
and one Complete tablet per 25 ml) for 10 min. The tissues were homog-
enized by 20 strokes of a 3 ml Dounce homogenizer, and the NaCl con-
centration was adjusted to 155 mM. Homogenate was centrifuged at
1000 g for 5 min to pellet intact cells and other debris. Membranes were
recovered from the supernatant by centrifugation at 100,000  g for 40
min. The resulting membrane pellet was resuspended in 500 l of solu-
Figure 1. P2X7 Abs and P2X7 receptor knock-out mice constructs. A, P2X7 receptor subunit
topology and the corresponding positions against which the various Abs have been raised. The
construct of the Pfizer P2X7
/ ( B) has nucleotides 1527–1607 deleted and a neomycin cas-
sette inserted 5 to 3, whereas the construct of the GlaxoP2X7
/mice ( C) had a LacZ gene
inserted after ATG at the 5 end. D shows typical immunostaining for each of the three Abs in
HEK293 cells transiently transfected with mP2X7 cDNA (top micrographs) or untransfected cells
(bottom micrographs). The Cterm-Ab was highly selective in HEK cells; the ectoAb-1 nonspe-
cifically stained nuclei, but the cytoplasmic/plasma membrane staining was only seen in trans-
fected cells, and the ectoAb-2 staining did not show any obvious selectivity. In separate exper-
iments with enhanced green fluorescent protein (GFP) cotransfection, only GFP-positive cells
were immunopositive with the Cterm-Ab, thus further supporting its selectivity.
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bilization buffer [20 mM dodecyl-D-maltoside (DM) in PBS plus protease
inhibitors] and incubated on a rotating wheel for 16 hr at 4°C. After
centrifugation at 13,000 rpm for 10 min in a refrigerated microfuge, the
protein content of the solubilized membranes (supernatant) was deter-
mined using a protein assay kit (Bio-Rad, Hercules, CA). Samples of
solubilized membranes were mixed with an equal volume of SDS loading
buffer and boiled for 2 min to denature. Equal amounts of protein from
the solubilized membranes were separated by SDS-PAGE on 8% gels and
transferred electrophoretically to polyvinylidene difluoride (PVDF)
membranes (Bio-Rad). Total cell lysates were used as positive controls
for immunoblotting; these were obtained by lysing 2 10 6 cells in 50 l
of solubilization buffer and denaturing in an equal volume of SDS load-
ing buffer, and 4 l of this solution was loaded onto gels. The amount of
protein loaded from the mouse tissues is indicated in the figure legends.
PVDF membranes were rinsed in TBS (10 mM Tris and 250 mM NaCl, pH
7.5) and then blocked with 5% milk in TTBS (TBS plus 0.2% Tween 20)
for 1 hr at room temperature. Primary Abs were applied at the appropri-
ate concentration in blocking solution and incubated overnight at 4°C.
Membranes were washed three times with TTBS, and a secondary Ab was
added in blocking solution for 1 hr at room temperature. Membranes
were washed four times in TTBS, and Western Lightning substrate (NEN
Life Science, Boston, MA) was applied for 1 min. The blots were then
exposed to Kodak Bio-max Light film, and the films were developed
using an Optimax developing machine (IGP, Chelmsford, UK). The pri-
mary Abs and their dilutions were: Cterm-Ab (1:5000), ectoAb-1 (1:
1000), and ectoAb-2 (1:5000). Secondary Ab was used at a 1:2000
dilution.
Immunoprecipitation. Membrane proteins from mouse tissues were
solubilized using the same technique as for
Western blotting, except that 2% (w/v) Triton
X-100 was used instead of DM. Samples of sol-
ubilized membrane proteins were made up to
500 l in PBS containing 2% (w/v) Triton
X-100 plus protease inhibitors (IP buffer).
Gamma-bind G Sepharose beads (25l; Amer-
sham) were added to clear the membrane solu-
bilizates, and the mixtures were tumbled for 3
hr at 4°C. After centrifugation to pellet the
beads, supernatants were transferred to fresh
tubes, 1 l of C-terminal Ab (Alomone) was
added, and the mixtures were tumbled for 2 hr
at 4°C. Gamma-bind G Sepharose beads (25l)
were added, and the mixtures were incubated
overnight at 4°C to allow binding of immune
complexes to the beads. After incubation, beads
were recovered by centrifugation and washed
six times in 0.5 ml of IP buffer. Washed beads
were heated in SDS-PAGE sample buffer at
100°C for 5 min to denature and elute bound
proteins, and the resultant mixtures were sepa-
rated by SDS-PAGE and subjected to Western
blotting as described above, using the Cterm-
Ab. These blots then resulted in strong staining
of the Ig heavy chain at 50 kDa, but this did
not interfere with detection of the 75 kDa P2X7
receptor protein band (see Fig. 7B).
X-gal staining. Cryostat sections of subman-
dibular glands (10 m) and brain tissues (12
m) were cut and collected on SuperFrost Plus
slides (VWR). The tissues were postfixed in cold
(4°C) PBS containing 0.2% glutaraldehyde, 5
mM EGTA, and 2 mM MgCl2, pH.7.2, for 5 min,
washed for 1 min in H2O, and left to air dry. The
sections were then washed in rinse buffer con-
taining 1 mM MgCl2 and 0.1% Triton X-100 in
PBS at room temperature. The sections were
then immersed in X-gal solution (5 mM potas-
sium ferricyanide, 5 mM potassium ferrocya-
nide, and 4 mg/ml 5-bromo-4-chloro-3-
indoyl--D-galactosidase made up in rinse
buffer) for 4 –24 hr at 37°C to reveal transgene-expressing cells in the
brain. Sections were counterstained with Neutral Red to highlight the
cellular localization of the blue X-gal staining. All sections were mounted
with glycerin and viewed on a Axiovert C25 microscope (Zeiss, Welwyn
Garden City, UK). Images were taken with an Axiocam camera and
Image Associates software (Zeiss).
Results
Immunohistochemistry
Wild-type rat and mouse brain
We used three Abs directed toward separate epitopes of the P2X7
receptor: Cterm-Ab, EctoAb-1, and ectoAb-2 (Fig. 1A). These
Abs have been used in previously published reports examining
P2X7 receptor localization and function in neuronal and non-
neuronal tissues (Worthington et al., 1999a,b; Deuchars et al.,
2001; Kim et al., 2001; Sluyter et al., 2001; Armstrong et al., 2002;
Atkinson et al., 2002, 2004; Le Feuve et al., 2002; Lundy et al.,
2002; Sperlagh et al., 2002; Ishii et al., 2003). We found that
Cterm-Ab, but not ectoAb-1 or ectoAb-2, were highly selective
for P2X7 receptor protein when expressed in HEK293 cells and
compared with untransfected (Fig. 1D) and P2X1– 6 receptors
individually transfected into these cells (data not shown). Initial
studies performed on rat brain with each Ab showed different
patterns of P2X7 immunoreactivity (P2X7-IR) depending on the
Ab used and the protocols used (see Materials and Methods). In
Figure 2. Discrete staining patterns obtained with different P2X7 Abs in wild-type rat and mouse hippocampus. Sagittal views
of adult rat and mouse hippocampi are shown at both 10 and 40magnification for each Ab used and detected with Ni-DAB
as described in Materials and Methods. Cterm-Ab revealed punctate staining indicative of mossy terminal input from the dentate
gyrus in both rat and mouse (A, B, E, F ), whereas ectoAb-2 primarily stained astrocytes scattered throughout the hippocampus (C,
D, G, H ). The ectoAb-2 also showed immunopositive neurons in the CA3 region of rat but not mouse (D, H ). The ectoAb-1 stained
large “interneuronal-like” cells within the CA3 region (I, J ). Scale bars: A, C, E, G, I, 100m; B, D, F, H, J, 50m.
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agreement with previous studies using the Cterm-Ab (Armstrong
et al., 2002; Atkinson et al., 2004), we could find P2X7-IR in
microglia-like cells and punctate staining in the CA3 region of the
hippocampus that was compatible with mossy fiber terminals
(Fig. 2A,B), although other staining patterns, such as neuronal
cell body immunoreactivity could also be observed by slightly
altering the fixation, incubation protocols, or both. In contrast,
ectoAb-2 produced strong staining in astrocytes and neuronal
somata in CA3 but no evidence of mossy fiber staining (Fig.
2C,D). Several different fixation and staining protocols were
tried, which again resulted in different patterns of P2X7-IR
throughout the hippocampus and other regions of the brain;
however, under no condition did we observe a similar pattern of
staining by the Cterm and ectoAb Abs. Thus, it was not possible
to determine which staining pattern, if any, could be considered a
reliable indication of P2X7 receptor protein expression in rat
brain.
Therefore, we turned our attention to the mouse model in
which P2X7 knock-out mice are available to assess which pattern
of immunoreactivity might adequately represent P2X7 receptor
protein expression. Staining patterns in wild-type mouse brain
were very similar to those obtained in rat brain; these initial re-
sults provided us with good evidence that results obtained in
mouse brain may also be considered representative for rat central
neurons, in which the majority of functional studies have been
performed. Strong mossy fiber staining was observed with the
Cterm-Ab similar to that observed in rat hippocampus (Fig.
2E,F). EctoAb-2 stained mainly astrocytic cells but no neuronal
cell bodies or terminals in the CA3 region (Fig. 2G,H), whereas
the ectoAb-1 stained large interneuronal-like cells scattered
within the pyramidal layer and dentate gyrus with some weak
staining in neurons within the pyramidal layers (Fig. 2 I, J).
P2X7
/ mice
Results from immunolocalization with the three Abs in the
knock-out and their respective control mice are shown in Figures
3 (Pfizer P2X7
/) and 4 (GlaxoP2X7
/). The overall intensity
of staining with the Cterm-Ab was reduced in the Pfizer P2X7
/
mouse brain compared with control (Fig. 3A,D), and no
microglial-like cells were observed (Fig. 3D), but the punctate
immunoreactivity in the mossy fibers of the dentate gyrus and
projections to the CA3 region were still observed (Fig. 3D). There
were no apparent differences in immunoreactivity between the
control and Pfizer P2X7
/mouse brain using either of the other
two Abs (Fig. 3B–F). We observed no alterations in the staining
patterns or reduction in intensity between control and
GlaxoP2X7
/ mice with any of the Abs (Fig. 4), although a
consistent increase in the intensity of immunoreactivity by all
three Abs was observed in the GlaxoP2X7
/ mouse brain (Fig.
4E–H).
Submandibular gland
In striking contrast to the lack of specificity for P2X7 receptor
immunoreactivity by the different P2X7 Abs in the brain, similar
immunostaining of submandibular glands were observed with
both the Cterm-Ab and ectoAb-1 in wild-type mice, and this
staining disappeared in the knock-out mice. Figure 5 shows typ-
ical P2X7 immunoreactivity in 10-m-thick coronal sections of
submandibular glands from Pfizer P2X7
/ and GlaxoP2X7
/
mice and their respective controls. Immunoreactivity was present
as diffuse staining throughout duct cells of wild-type glands with
both Abs; the only difference was that the Cterm-Ab also stained
nuclei of both duct and acinar cells, but this nuclear staining was
not altered in the knock-out tissues (Fig. 5A), indicating that the
nuclear staining is most likely a nonspecific reaction to this par-
ticular Ab. A previous study has also observed immunolocaliza-
tion in nuclei of hippocampal neurons using this Ab (Atkinson et
al., 2002).
Western blots
Previous studies on brain and peripheral tissues have used these
Abs to examine P2X7 receptor protein expression by Western blot
analysis and have seen strong bands at the appropriate size
(73–78 kDa) (Worthington et al., 1999a,b; Deuchars et al., 2001;
Kim et al., 2001; Sluyter et al., 2001; Armstrong et al., 2002; At-
kinson et al., 2002, 2004; Le Feuve et al., 2002; Sperlagh et al.,
2002). Thus, it seemed reasonable to assume that although im-
munohistochemical localizations in the brain are unlikely to be
reliable with these Abs, they may still provide an adequate means
to determine and compare P2X7 protein levels in central and
peripheral tissues. We sought to verify this assumption by per-
forming Western blots from the brain, lung, and submandibular
glands of wild-type and knock-out mice, as well as from HEK293
cells transfected with mouse P2X7 cDNA (mP2X7/HEK). In all
experiments, a band running at 75 kDa was detected in mP2X7/
HEK, which corresponds to the expected molecular weight for
P2X7 (Kim et al., 2001). Typical results obtained from knock-out
mice tissue and their respective controls are shown in Figure 6. All
of the Abs detected a band at 75 kDa in all tissues from wild-type
mice, with the Cterm-Ab showing the highest level of discrimi-
nation (i.e., there were fewer bands of inappropriate size ob-
served with this Ab) (Fig. 6). This 75 kDa band was completely
absent from the lung and submandibular glands obtained from
both sets of P2X7
/ tissues when probed with either the
Figure 3. P2X7 Ab immunoreactivity is unaltered in Pfizer P2X7
/ knock-out mice. The
sagittal view of the staining pattern using the Ni-DAB protocol of the three P2X7 receptor Abs in
hippocampal sections in wild-type (C57B/L6DBA) ( A–C) and in Pfizer P2X7
/mice ( D–F)
is shown. No clear or consistent differences in staining were observed with any of the three Abs
using this or other staining protocols. Scale bar, 40m.
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Cterm-Ab or the ectoAb-1, but there was
no difference in the 75 kDa bands detected
from brains of the same knock-out ani-
mals (Fig. 6A,B). There were no differ-
ences in the 75 kDa (or other) bands ob-
served in any tissues from wild-type or
knock-out mice using the ectoAb-2, and
additionally it produced very high back-
ground staining at dilutions (1:5000) re-
quired to detect the 75 kDa band (Fig. 6C).
Immunoprecipitation
Our results show that the Cterm-Ab can
clearly detect P2X7 protein in the subman-
dibular gland and lung on Western blots
but not in the brain. If the P2X7 protein is
significantly present in the brain, it is likely
masked by the presence of brain-specific
proteins of a similar size that are also de-
tected by this Ab (Fig. 7A). We therefore
pursued the use of this Ab in immunopre-
cipitation experiments in an attempt to
eliminate the contaminating protein(s).
Control experiments on the submandibu-
lar gland, which contained no discernible
contaminating protein at 75 kDa (based
on its total disappearance in knock-out tis-
sue) (Figs. 6, 7A), indicated that there was
little loss of P2X7 receptor protein after the
immunoprecipitation protocol (20 g for
both Western blot only and immunopre-
cipitation/Western blot) (Fig. 7B, lane 1 vs
lane 3). When the same amount of brain
membrane protein (20 g) was loaded af-
ter immunoprecipitation of a 100 g total
membrane fraction, no 75 kDa band was
observed from either wild-type or knock-
out mice (Fig. 7B, lanes 7 and 8). More-
over, even running 40 times as much brain
protein (4 mg) through the immunopre-
cipitation and loading all of the recovered
protein onto the Western blot still failed to
detect any 75 kDa band in the wild-type or
knock-out brain (Fig. 7B, lanes 9 and 10,
C). These results suggest that the immuno-
precipitation did remove all or most of the
contaminating protein from the brain and
that levels of P2X7 protein in the brain, if
present, are at least 200 times lower than in
the submandibular gland.
Transgene expression
of -galactosidase
An indirect assay for P2X7 protein expres-
sion and cellular localization was provided
by the GlaxoP2X7
/ mice in which the
LacZ gene had been inserted into the P2X7
gene. X-gal staining for -galactosidase,
the protein encoded by the LacZ gene, re-
vealed positive cells in the ependyma (Fig.
8A,B) but not in pyramidal cell layers or
the dentate gyrus of the hippocampus (Fig.
Figure 5. P2X7 Ab immunoreactivity is absent from the submandibular glands of P2X7 knock-out mice. Cterm-Ab shows strong
Ni-DAB-positive duct cells with weaker staining apparent in acinar cells in wild-type mice but not in Pfizer or Glaxo knock-out mice
( A), although the nuclear staining pattern is unaltered and represents nonspecific staining. The ectoAb-1 shows a very similar
pattern of immunoreactivity in duct and acinar cells in wild-type submandibular glands; virtually all immunoreactivity disap-
peared in knock-out submandibular glands ( B). Scale bars, 40m.
Figure 4. P2X7 Ab immunoreactivity is unaltered in GlaxoP2X7
/mice. Sagittal views of the staining patterns of the three
Abs in hippocampal sections from wild-type C56B/L6 ( A–D) and GlaxoP2X7
/ mice ( E–H) are shown. The only consistent
differences observed were an increase intensity of punctate staining in the mossy fiber region from knock-out mice using the
Cterm-Ab (compare B with F ) and the appearance of immunopositive neurons in the CA3 region with the ectoAb-2 in the
knock-out mice that was absent in the wild-type mice (compare D with H ). Scale bars: A, E, 100m; B–D, F–H, 40m.
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8C,D). X-gal staining was prominent in both acinar and duct cells
of submandibular gland sections from these mice (data not
shown).
Discussion
The traditional hallmark of reliability and accuracy in immuno-
cytochemical localization of proteins is a finding of similar cellu-
lar localization using multiple Abs directed at different epitopes
of the protein of interest. This hallmark has been well fulfilled in
the brain for localization of P2X4 receptors and in autonomic–
sensory–spinal systems for P2X1, P2X2, and P2X3 receptors (Vul-
chanova et al., 1997; Le et al., 1998; Kanjhan et al., 1999; Chizh
and Illes, 2000; Dunn et al., 2001; Rubio and Soto, 2001). In
contrast, our inability to detect similar patterns of expression in
the hippocampus and other brain areas of adult rats using the
available P2X7 Abs, as well as similar inconsistencies in the recent
literature (Worthington et al., 1999a,b; Deuchars et al., 2001; Kim
et al., 2001; Sluyter et al., 2001; Armstrong et al., 2002; Atkinson
et al., 2002, 2004; Lundy et al., 2002; Sperlagh et al., 2002; Ishii et
al., 2003), led us to undertake the present study in the mouse, in
which two knock-out models are available. Except for a nonspe-
cific nuclear staining, the two commercially available Abs were, in
fact, highly selective for P2X7 receptors expressed in HEK cells
and showed identical staining patterns in the submandibular
gland and peripheral macrophage; moreover, all immunocyto-
chemical staining disappeared (except for the nuclear staining
with Cterm-Ab) in submandibular glands from both the
GlaxoP2X7
/ and the Pfizer P2X7
/ mice. The two Alomone
Abs, but not ectoAb-2, also detected the P2X7 receptor protein in
the lung and submandibular gland (Figs. 6, 7) as well as in isolated
microglia and macrophage because no 75 kDa band could be
detected from any of these peripheral tissues in the knock-out
mice (Sikora et al., 1999; Labasi et al., 2002; Le Feuvre et al., 2002).
Finally, LacZ transgene expression of-galactosidase was present
in these peripheral tissues from GlaxoP2X7
/ mice. Taken to-
gether, our results do provide very convincing evidence for P2X7
protein expression and detection (by two of the three P2X7 recep-
Figure 6. Western blots with P2X7 Ab in brain and peripheral tissues from wild-type and
knock-out mice reveals non-P2X7 protein running at the same size as P2X7 in the brain but not
peripheral tissue. Membrane extracts of wild-type (WT) and knock-out (KO) mouse brain, lung,
and submandibular gland (Subman) were subjected to SDS-PAGE on 8% (w/v) gels, followed by
Western blotting as described in Materials and Methods. Extracts of HEK cells expressing mouse
P2X7 were used as positive controls in each blot. For each Ab ( A–C), left gels show results from
the brain and right gels are from the lung and submandibular gland. The 75 kDa bands observed
in the lung and submandibular glands using the Cterm-Ab ( A) and ectoAb-1 ( B) Abs were
absent from both knock-out mice, but there were no differences in any bands detected by these
Abs in brain tissue. The ectoAb-2 detected several size bands in all tissues examined, including
a 75 kDa band, but none were altered in any tissue from knock-out mice ( C), rendering this Ab
unsuitable for detection of the P2X7 receptor protein. A, For Cterm-Ab (1:5000 dilution), equal
loadings of 0.5 g of brain, 16 g of lung, and 16 g of submandibular gland membrane
protein were used. B, For ectoAb-1 (1:1000 dilution), equal loadings were 25, 16, and 16g for
brain, lung, and submandibular gland, respectively. C, For ectoAb-2 (1:5000 dilution), loadings
were 25, 16, and 16g, respectively.
Figure 7. Immunoprecipitation with Cterm-Ab removes contaminating 75 kDa protein from
brain but does not unmask P2X7 receptor protein. A, Typical results from a single Western blot
reveals the absence of the 75 kDa band in the lung and submandibular glands from knock-out
mice but no change in staining in the brain from the same animals. B, Typical results from
Western blots (lanes 1, 2, 5, 6) and after immunoprecipitation (lanes 3, 4, 7–10); a composite of
two separate experiments is shown, as indicated by the vertical bar. The first four lanes are an
experiment comparing equal amounts of submandibular gland membrane protein (20 g)
from wild-type and knock-out mice; no significant difference in the amount of 75 kDa protein
detected was observed after immunoprecipitation from the submandibular gland of wild-type
mice (lanes 1, 3), and this band disappeared from knock-outs (lanes 2, 4). Lanes 5–10 show a
separate, but similar, experiment on brain tissue; here, 2g of brain membrane protein was
loaded for the Western blot only (lanes 5, 6), a 20g equivalent (lanes 7, 8) or 4000g after
immunoprecipitation (lanes 9, 10). This protocol virtually eliminated the 75 kDa band in both
wild-type and knock-out brain (lanes 7–10). C, Denisitometry analysis of all results from exper-
iments shown in A and B; the numbers above each bar represent the number of experiments.
KO, Knock-out; WT, wild type; IP, immunoprecipitation; subman, submandibular gland.
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tor Abs) in these peripheral immune and epithelial cells as well as
equally convincing evidence for the absence of this protein in
both P2X7
/ mice lines.
In direct contrast to these results, none of the Abs could iden-
tify P2X7 receptor expression in neurons, either by immunocyto-
chemical localizations or by Western blots. Not only did none of
the Abs give a similar pattern of staining to one another, but there
was also little or no difference in either of the knock-out mice by
immunocytochemistry or by Western blot with any of the Abs.
Clearly, these Abs also recognize other proteins in brain that are
not present in non-neuronal tissues that we and others have ex-
amined (Sikora et al., 1999; Suh et al., 2001; Labasi et al., 2002; Le
Feuvre et al., 2002, 2003; Guerra et al., 2003; Rothwell, 2003), in
particular one (or more) that runs at the same 75 kDa size as does
the P2X7 protein. We attempted to eliminate the contaminating
protein(s) and unmask brain P2X7 protein by immunoprecipita-
tion before immunoblot; no 75 kDa band was observed using this
protocol, except for a weak signal when 40- to 100-fold greater
amounts of total brain membrane protein were used, and even
this remaining signal was not altered in the knock-out mice.
Moreover, no transgene expression of -galactosidase could be
detected in the hippocampal pyramidal cell layer or dentate gy-
rus, although it was readily apparent in ependymal cells lining the
ventricle (Fig. 8). The only reasonable explanation for all of these
results is that P2X7 receptor protein is either not expressed in
neurons of the normal adult rodent brain, or that levels are too
low to be detected by any method currently available. This expla-
nation would be in keeping with previous results that detected
expression of P2X7 receptor only in microglia surrounding an
area of inflammation evoked by prior occlusion of the middle
cerebral artery (Collo et al., 1997). In any event, a clear conclu-
sion can be reached concerning the use of these P2X7 receptor
Abs in the brain: they are neither selective nor reliable. However,
it is possible that the immunoprecipitation protocol we devel-
oped may be adequate under conditions in which P2X7 protein
levels are upregulated, as is known to occur in isolated microglial
cells in response to inflammatory stimuli (Di Virgilio et al., 2001;
Rothwell, 2003).
Recent functional studies, in combination with immunolocal-
ization using the same Abs we used in this study, have concluded
that presynaptic P2X7 receptors in the hippocampus may modu-
late synaptic transmission at these sites (Armstrong et al., 2002;
Lundy et al., 2002; Sperlagh et al., 2002; Atkinson et al., 2004;
Cavaliere et al., 2004). However, extracellular ATP activates not
only ionotropic P2X receptors but also metabotropic P2Y recep-
tors and, because it is readily broken down to adenosine, adeno-
sine receptors. In particular, there is extensive evidence for inhi-
bition of both glutamatergic excitatory and GABA inhibitory
synaptic transmission at mossy fiber terminals in hippocampal
CA3 by presynaptically localized adenosine receptors (Malva et
al., 2003; Kato et al., 2004). We found that 2-3-O-(4-
benzoylbenzoyl)-ATP (BzATP) produces a slow-onset inhibition
of both evoked glutamatergic EPSCs and TTX-insensitive spon-
taneous GABAergic miniature IPSCs in CA3 of adult rat and
mouse in the absence, but not in the presence, of the adenosine
receptor blocker 8-cyclopentyl-1,3-dipropylxanthine (J. Sim, E.
Tanaka, and F. Kato, unpublished observations). Thus, it is pos-
sible that the BzATP-induced presynaptic inhibition of mossy
fiber excitatory input to CA3 neurons observed by Armstrong et
al. (2002) may have been attributable to ATP hydrolysis to aden-
osine. Moreover, P2Y receptors and other P2X receptors (P2X2,
P2X4, P2X6) have been shown to act presynaptically in both the
CA1 and CA3 regions of the hippocampus (North and Barnard,
1997; Brown et al., 2000; Norenberg and Illes, 2000; Khakh, 2001;
Mori et al., 2001; Robertson et al., 2001; North, 2002; Malva et al.,
2003); any of these receptors may also be targeted by breakdown
of extracellular ATP. Certainly, recent functional studies on brain
slices from wild-type and P2X2
/ knock-out mice provide
strong support for P2X2 receptors playing a role in presynaptic
modulation of transmitter release at hippocampal interneurons
(Khakh et al., 2003).
Our study has failed to provide any evidence for neuronal
localization of P2X7 receptors in neurons of the rodent brain, but
synthesis and membrane localization of these receptors in im-
mune cells are rapidly upregulated in response to inflammatory
stimuli (North, 2002; Guerra et al., 2003; Rothwell, 2003). In view
of the apoptotic signaling cascades uniquely induced by activa-
tion of P2X7 receptors in immune cells, it remains an important
neuroscience issue to determine whether this ATP-gated ion
channel may be similarly turned on in brain neurons after isch-
emic damage or other inflammatory diseases of the brain.
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